Skip to main content
Home
language-selector-globe Czech Republic | en
Choose Location
language-selector-globe Czech Republic |
CzechEnglish
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Novartis Foundation | en
Sandoz | en
Egypt | en
Israel | he
South Africa | en
Turkey | tr
language-selector-globe Czech Republic
Choose Location
language-selector-globeCzech Republic
CzechEnglish
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Global | en
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis Foundation | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Novartis in the Czech Republic 
      • Strategy 
      • Diversity and inclusion 
      • People and culture 
      • Products 
      • Country leadership team 
      • Our mission and vision 
      • Innovative medicines 
      • Contact 
      Novartis Česká republika About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Our patient portals for Czech Republic 
      • Products 
      • Adverse event reporting 
      • Provision of gifts and grants 
      Babička s vnučkou v objetí Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Products 
      • Novartis pipeline 
      • Adverse event reporting 
      • Novartis clinical trials 
        • Clinical trials in Czech Republic 
      • VPOIS 
      • Expert information 
      Vědec se dívá do mikroskopu Healthcare Professionals
    • Research and development 
      • Research and development in Czech Republic 
      Vědkyně v laboratoři Research and development
    • ESG 
      • Ethics, risk and compliance 
      • Access 
      • Environmental sustainability 
      • Global health 
      • Ethical behavior 
      • Whistleblow line 
      Ruka na rozpukané vyprahlé hlíně ESG
    • News 
      • News archive 
      • Stories 
      • Media library 
      • Media contacts 
      Diskutující lidé s notebooky nad odbornými články News
    • Careers 
      • Career search 
      • Meet the teams 
      • Personal growth 
      • Early talent 
      • How we work 
      • Leadership trainee program 
      • Well-being 
      • Diversity and inclusion 
      • Awards and recognition 
      Usmívající se žena v posluchárně Careers
    • Coronavirus 
      Částice viru SARS CoV 2 na snímku z elektronového mikroskopu. Coronavirus
    Female scientist in laboratory Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort descending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort descending Site Location Division Business Functional Area Date Posted
(Senior) Clinical Development Medical Director - Rheumatology East Hanover USA Development Innovative Medicines Research & Development May 20, 2024
(Senior) Medical Advisor (Radioligand Therapy) Hong Kong Hong Kong Special Administrative Region, China International Innovative Medicines Research & Development Oct 09, 2024
(Senior) MSL Manager, LC Shanghai (Shanghai) China International Innovative Medicines Research & Development Sep 18, 2024
(Senior) QA Operations Specialist Schaftenau Austria Operations Innovative Medicines Quality Sep 26, 2024
(Sr.) Regional Sales Manager, ONCO (Central & South) Kao Hsiung Taiwan International Innovative Medicines Sales Aug 12, 2024
(Sr.) Sales Executive-OPH Hong Kong Hong Kong Special Administrative Region, China International Innovative Medicines Sales Jun 12, 2024
(Sr.) Sales Executive-Solid Tumor Hong Kong Hong Kong Special Administrative Region, China International Innovative Medicines Sales Aug 22, 2024
(高级)区域市场经理 Zhengzhou (Henan Province) China International Innovative Medicines Marketing Apr 30, 2024
(高级)区域市场经理 Xian (Shanxi Province) China International Innovative Medicines Marketing Sep 05, 2024
(高级)医药代表 /(资深)产品专员 Nanchong (Sichuan Province) China International Innovative Medicines Sales Sep 10, 2024
(高级)医药代表 /(资深)产品专员 Hangzhou (Zhejiang Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)医药代表 /(资深)产品专员 Taiyuan (Shanxi Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Sep 24, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Sep 25, 2024
(高级)医药代表 /(资深)产品专员 Anyang (Henan Province) China International Innovative Medicines Sales Apr 10, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Kunming (Yunnan Province) China International Innovative Medicines Sales May 15, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Jun 05, 2024
(高级)医药代表 /(资深)产品专员 Chuzhou (Anhui Province) China International Innovative Medicines Sales Jun 06, 2024
(高级)医药代表 /(资深)产品专员 Shantou (Guangdong Province) China International Innovative Medicines Sales Jun 18, 2024
(高级)医药代表 /(资深)产品专员 Hefei (Anhui Province) China International Innovative Medicines Sales Jul 01, 2024
(高级)医药代表 /(资深)产品专员 Zhanjiang (Guangdong Province) China International Innovative Medicines Sales Jul 01, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Aug 30, 2024
(高级)医药代表 /(资深)产品专员 Xianyang (Shanxi Province) China International Innovative Medicines Sales Aug 30, 2024
(高级)医药代表 /(资深)产品专员 Kunming (Yunnan Province) China International Innovative Medicines Sales May 15, 2024
(高级)医药代表 /(资深)产品专员 Fuzhou (Fujian Province) China International Innovative Medicines Sales May 17, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Sep 29, 2024
(高级)医药代表 /(资深)产品专员 Xian (Shanxi Province) China International Innovative Medicines Sales Sep 29, 2024
(高级)医药代表 /(资深)产品专员 Xian (Shanxi Province) China International Innovative Medicines Sales Sep 29, 2024
(高级)医药代表 /(资深)产品专员 Guiyang (Guizhou Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Kunming (Yunnan Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Kunming (Yunnan Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Yibin (Sichuan Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Anyang (Henan Province) China International Innovative Medicines Sales Apr 10, 2024
(高级)医药代表 /(资深)产品专员 Hangzhou (Zhejiang Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)医药代表 /(资深)产品专员 Taiyuan (Shanxi Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Sep 24, 2024
(高级)医药代表 /(资深)产品专员 Nanchong (Sichuan Province) China International Innovative Medicines Sales Sep 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Sep 25, 2024
(高级)医药代表 /(资深)产品专员 Yibin (Sichuan Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Guiyang (Guizhou Province) China International Innovative Medicines Sales Oct 09, 2024

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Czech Republic

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
  • Adverse event reporting
Media Center
  • News archive
  • Stories
Our Portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis websites
  • Global
Footer Bottom
© 2024 Novartis s.r.o
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in the Czech Republic